Last reviewed · How we verify

NCT05759481: PONV

Prevention of Post-Operative Nausea and Vomiting With Propofol Infusion

Completed Phase 2 Last updated 2 April 2025
What this trial tests

Phase 2 trial testing Propofol in Post-operative Nausea and Vomiting in 68 participants. Completed in 12 March 2025.

Timeline
1 February 2024
Primary endpoint
12 March 2025
12 March 2025

Quick facts

Lead sponsorMilton S. Hershey Medical Center
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment68
Start date1 February 2024
Primary completion12 March 2025
Estimated completion12 March 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Milton S. Hershey Medical Center

Who can join

18 and older, any sex, with Post-operative Nausea and Vomiting. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to clarify whether or not a low-dose propofol infusion can effectively prevent postoperative nausea and vomiting (PONV) in patients who have a documented history of PONV and/or motion sickness.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of low-dose propofol infusion with sevoflurane versus propofol-only total intravenous anesthesia on postoperative nausea and vomiting in high-risk patients: a single-blind randomized controlled clinical trial.
    Keck WL, Deng E, Liu WM, Kanekar R, et al · · 2026 · cited 1× · PMID 41593496 · DOI 10.1186/s12871-026-03649-7

Verify or expand the search:

Other trials of Propofol

Trials testing the same drug.

Other Milton S. Hershey Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05759481.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing